A major discovery in cancer study is emerging with the use of nanobodies to re-engage damaged p53. This crucial malignant inhibitor protein is frequently disabled in various kinds of cancer, causing uncontrolled cell https://enrollbookmarks.com/story21876219/nanobodies-reactivate-p53-the-potential-pathway-for-malignant-management